Lupin Limited has informed the Exchange regarding a press release dated December 17, 2025, titled "Lupin Receives Positive CHMP Opinion for Biosimilar Ranibizumab".
Lupin Limited has informed the Exchange regarding a press release dated December 17, 2025, titled "Lupin Receives Positive CHMP Opinion for Biosimilar Ranibizumab".